These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 28230646)
1. Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation. Nelson LM; Andreassen AK; Andersson B; Gude E; Eiskjær H; Rådegran G; Dellgren G; Gullestad L; Gustafsson F Transplantation; 2017 Nov; 101(11):2793-2800. PubMed ID: 28230646 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial. Bollano E; Andreassen AK; Eiskjaer H; Gustafsson F; Rådegran G; Gude E; Gullestad L; Broch K; Halden TAS; Karason K; Bartfay SE; Bergh N; J Heart Lung Transplant; 2024 Jul; ():. PubMed ID: 39038562 [TBL] [Abstract][Full Text] [Related]
3. Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation. Rudzik KN; Schonder KS; Humar A; Johnson HJ Clin Transplant; 2024 Jul; 38(7):e15402. PubMed ID: 39023099 [TBL] [Abstract][Full Text] [Related]
4. Impact of Everolimus Initiation and Corticosteroid Weaning During Acute Phase After Heart Transplantation on Clinical Outcome: Data from the Korean Organ Transplant Registry (KOTRY). Lee KS; Kim H; Lee SH; Choi DJ; Yoon M; Jeon ES; Choi JO; Kang J; Lee HY; Jung SH; Oh J; Kang SM; Lee SY; Ju MH; Kim JJ; Kim MS; Cho HJ Transpl Int; 2024; 37():11878. PubMed ID: 38644935 [TBL] [Abstract][Full Text] [Related]
5. A quantitative assessment of renal function utilizing albuminuria in pediatric heart transplant recipients. Frandsen EL; Kronmal RA; Albers EA; Friedland-Little JM; Hong BJ; Spencer KL; Hingorani SR; Law YM Clin Transplant; 2024 Feb; 38(2):e15253. PubMed ID: 38369813 [TBL] [Abstract][Full Text] [Related]
6. Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis. Cornu C; Dufays C; Gaillard S; Gueyffier F; Redonnet M; Sebbag L; Roussoulières A; Gleissner CA; Groetzner J; Lehmkuhl HB; Potena L; Gullestad L; Cantarovich M; Boissonnat P Br J Clin Pharmacol; 2014 Jul; 78(1):24-32. PubMed ID: 24251918 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials. Liu J; Liu D; Li J; Zhu L; Zhang C; Lei K; Xu Q; You R PLoS One; 2017; 12(1):e0170246. PubMed ID: 28107397 [TBL] [Abstract][Full Text] [Related]
8. Use of everolimus in liver transplantation. Yee ML; Tan HH World J Hepatol; 2017 Aug; 9(23):990-1000. PubMed ID: 28878864 [TBL] [Abstract][Full Text] [Related]
9. Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma. Kang I; Lee JG; Choi SH; Kim HJ; Han DH; Choi GH; Kim MS; Choi JS; Kim SI; Joo DJ Clin Mol Hepatol; 2021 Oct; 27(4):589-602. PubMed ID: 34293849 [TBL] [Abstract][Full Text] [Related]